Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference24 articles.
1. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year;Deshields;Support Care Cancer,2014
2. Patient-reported outcomes in metastatic castration-resistant prostate cancer;Fallowfield;Nat Rev Clin Oncol,2016
3. Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature;Moul;Cancer Invest,2012
4. Toward patient-centered drug development in oncology;Basch;N Engl J Med,2013
5. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov;Vodicka;Contemp Clin Trials,2007
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mental health care utilization among men with castration‐resistant prostate cancer receiving abiraterone or enzalutamide;Cancer Medicine;2023-06-16
2. Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review;Cancers;2022-08-03
3. Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study;ESMO Open;2022-04
4. Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden;Acta Oncologica;2021-09-17
5. Preserving Well-being in Patients With Advanced and Late Prostate Cancer;Urology;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3